Sara van den Berg

74 Chapter 3 21. Thompson, W.W., et al., Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA, 2003. 289(2): p. 179-86. 22. Lambert, N.D., et al., Understanding the immune response to seasonal influenza vaccination in older adults: A systems biology approach. Expert Review of Vaccines, 2012. 11(8): p. 985-994. 23. Pedersen, J.C., Hemagglutination-Inhibition Assay for Influenza Virus Subtype Identification and the Detection and Quantitation of Serum Antibodies to Influenza Virus , in Animal Influenza Virus , E. Spackman, Editor. 2014, Springer New York: New York, NY. p. 11-25. 24. Agency, E.M., Guideline on Influenza Vaccines. 2016. 25. Trzonkowski, P., et al., Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination--an impact of immunosenescence. Vaccine, 2003. 21(25-26): p. 3826-36. 26. Wald, A., et al., Impact of human cytomegalovirus (CMV) infection on immune response to pandemic 2009 H1N1 influenza vaccine in healthy adults. J Med Virol, 2013. 85(9): p. 1557-60. 27. Den Elzen, W.P., et al., Telomere length and anaemia in old age: results from the Newcastle 85-plus Study and the Leiden 85-plus Study. Age Ageing, 2011. 40(4): p. 494-500. 28. Furman, D., et al., Cytomegalovirus infection enhances the immune response to influenza. Sci Transl Med, 2015. 7(281): p. 281ra43. 29. Merani, S., et al., Impact of Aging and Cytomegalovirus on Immunological Response to Influenza Vaccination and Infection. Front Immunol, 2017. 8: p. 784. 30. de Bourcy, C.F., et al., Phylogenetic analysis of the human antibody repertoire reveals quantitative signatures of immune senescence and aging. Proc Natl Acad Sci U S A, 2017. 114(5): p. 1105-1110. 31. Moher, D., et al., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ, 2009. 339: p. b2535. 32. Center for Biologics Evaluation and Research, U.S.D.o.H.a.H.S. and F.a.D. Administration, Guidance for Industry Clinical Data Needed to Support the Licensure of Seasonal Inactivated Influenza Vaccines 33. Data Extraction and Assessment Template. Cochrane Handbook, The Cochrane Public Health Group. 34. Wells, G.A.S., B.; O’Connell, D.; Peterson, J.; Welch, V.; Losos, M.; Tugwell, P., The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri . ca/programs/clinical_epidemiology/oxford.asp. 35. Viechtbauer, W., ‘metafor’: Meta-analysis package for R. The Comprehensive R Archive Network (CRAN), 2016. 36. DerSimonian, R. and N. Laird, Meta-analysis in clinical trials. Control Clin Trials, 1986. 7(3): p. 177- 88. 37. Egger, M., et al., Bias in meta-analysis detected by a simple, graphical test. BMJ, 1997. 315(7109): p. 629-34. 38. Duval, S. and R. Tweedie, Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics, 2000. 56(2): p. 455-63. 39. Furman, D., et al., Cytomegalovirus infection enhances the immune response to influenza. Science Translational Medicine, 2015. 7(281). 40. Frasca, D., et al., Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine. Vaccine, 2015. 33(12): p. 1433-9. 41. Enani, S., et al., Impact of ageing and a synbiotic on the immune response to seasonal influenza vaccination; a randomised controlled trial. Clin Nutr, 2017.